You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 22, 2024

ZOMIG Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Zomig, and when can generic versions of Zomig launch?

Zomig is a drug marketed by Amneal, IPR, and Astrazeneca. and is included in three NDAs.

The generic ingredient in ZOMIG is zolmitriptan. There are twenty drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the zolmitriptan profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Zomig

A generic version of ZOMIG was approved as zolmitriptan by GLENMARK GENERICS on May 14th, 2013.

  Try a Trial

Paragraph IV (Patent) Challenges for ZOMIG
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
ZOMIG Nasal Spray zolmitriptan 2.5 mg/spray 021450 1 2016-06-09
ZOMIG Nasal Spray zolmitriptan 5 mg/spray 021450 1 2013-11-14

US Patents and Regulatory Information for ZOMIG

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal ZOMIG zolmitriptan SPRAY;NASAL 021450-003 Sep 16, 2013 AB RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Ipr ZOMIG zolmitriptan TABLET;ORAL 020768-002 Nov 25, 1997 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Amneal ZOMIG zolmitriptan SPRAY;NASAL 021450-004 Sep 30, 2003 AB RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ZOMIG

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ipr ZOMIG zolmitriptan TABLET;ORAL 020768-002 Nov 25, 1997 ⤷  Try a Trial ⤷  Try a Trial
Ipr ZOMIG zolmitriptan TABLET;ORAL 020768-001 Nov 25, 1997 ⤷  Try a Trial ⤷  Try a Trial
Amneal ZOMIG zolmitriptan SPRAY;NASAL 021450-004 Sep 30, 2003 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for ZOMIG

See the table below for patents covering ZOMIG around the world.

Country Patent Number Title Estimated Expiration
Finland 20001406 ⤷  Try a Trial
Hungary 219974 Heterociklusos csoporttal helyettesített indolszármazék, előállítása és a vegyületet hatóanyagként tartalmazó gyógyszerkészítmények (INDOLE DERIVATIVE SUBSTITUTED WITH HETEROCYCLIC GROUP, IT'S PREPARATION AS WELL AS PHARMACEUTICAL COMPOSITIONS COMPRISING SUCH COMPOUND AS ACTIVE INGREDIENTS) ⤷  Try a Trial
Russian Federation 2002117649 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for ZOMIG

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0463756 300048 Netherlands ⤷  Try a Trial PRODUCT NAME: ZOLMITRIPTANUM, DESGEWENST IN DE VORM VAN EEN FYSIOLOGISCH AANVAARDBAAR ZOUT OF VAN EEN SOLVAAT; NATL. REGISTRATION: RVG 21079 RVG 21080 19970925; FIRST REGISTRATION: PL 12619/0116 19970307
0486666 SPC/GB97/089 United Kingdom ⤷  Try a Trial PRODUCT NAME: ZOLMITRIPTAN AND OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT; REGISTERED: UK 12619/0116 19970307
0486666 72/1997 Austria ⤷  Try a Trial PRODUCT NAME: ZOLMITRIPTAN, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ZULAESSIGEN SALZES; NAT. REGISTRATION NO/DATE: 1-22068, 1-22069 19970819; FIRST REGISTRATION: GB 12619/0116, 12619/0117 19970307
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.